tirzepatide for psoriatic arthritis Ixekizumab + boosts outcomes more than Ixekizumab monotherapy The potential role of GLP-1

If you notice signs of dehydrationdark urine, persistent dry mouth, dizziness, or headachesincrease water intake by 1015 ounces daily and monitor for improvement over 2448 hours

Bristol Myers is abandoning a second CAR-T therapy, orva-cel (orvacabtagene autoleucel), and taking a US$ 470 million write-off

BPC-157 products sold as research use only are not the same as regulated medicines, and reports note concerns about limited human evidence, inconsistent purity, and unknown long-term safety

Growth hormone therapy studies document 24 kg of lean mass gain and 35 kg of fat loss over 612 months in aging populations